J&J’s Talc Winning Streak Continues With Calif. Mesothelioma Verdict
This article was originally published in The Rose Sheet
A California jury sided with J&J Nov. 16 in the first trial over whether alleged asbestos in the firm's talcum powders caused plaintiff's mesothelioma. The verdict could help check what threatens to be a new field of litigation against J&J for alleged talc dangers, and the firm also is gaining momentum in its defense against ovarian cancer claims.
You may also be interested in...
The iconic talc-based product will no longer be available for purchase in the US and Canada after supplies run out. Standing firm on the safety of Johnson’s Baby Powder, J&J attributes the move to declining demand due to changing consumer habits, misinformation “and a constant barrage of litigation advertising.”
SAI Lab Director ‘Elated’ By Federal Talc-Asbestos Testing Recs: ‘We Need To Be Aware That It’s There’
State-of-the-art testing approaches increasingly show that asbestos contamination of cosmetic talc is a concern worthy of the renewed attention it is receiving from federal agencies, says Scientific Analytical Institute’s research director Sean Fitzgerald.
Counsel for 22 women who blame J&J talcum powders for their ovarian cancer took a new approach in this latest case in St. Louis Circuit Court, arguing that asbestos in the firm’s talc is the culprit, rather than talc itself. J&J is confident in its ability to overturn the verdict, which it characterized as biased and unfounded.